MARATTO

article · Immunopharmacology and Immunotoxicology

Cardioprotective effect of tofisopam against isoprenaline-induced myocardial infarction in rats via modulation of NLRP3\IL-1β\caspase-1 pathway

20243 citationsMinia University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

Tofisopam protects against isoprenaline-induced MI through its antioxidant, anti-inflammatory, and anti-apoptotic properties.

Research topics

  • Eicosanoids and Hypertension Pharmacology
  • Traditional Chinese Medicine Analysis
  • Cardiac Ischemia and Reperfusion

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1080/08923973.2024.2421528

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.